Identification of a leukemic counterpart of the plasmacytoid dendritic cells

Blood

Volumn 97, Issue 10, 2001, Pages 3210-3217

  Chaperot, Laurence ^{a,b,c,d,e,f,g,h,i,j}   Bendriss, Nathalie ^{a,b,c,d,e,f,g,h,i}   Manches, Olivier ^{a,b,c,d,e,f,g,h,i}   Gressin, Rémy ^{a,b,c,d,e,f,g,h,i}   Maynadie, Marc ^{a,b,c,d,e,f,g,h,i}   Trimoreau, Franck ^{a,b,c,d,e,f,g,h,i}   Orfeuvre, Hubert ^{a,b,c,d,e,f,g,h,i}   Corront, Bernadette ^{a,b,c,d,e,f,g,h,i}   Feuillard, Jean ^{a,b,c,d,e,f,g,h,i}   Sotto, Jean Jacques ^{a,b,c,d,e,f,g,h,i}   Bensa, Jean Claude ^{a,b,c,d,e,f,g,h,i}   Brière, Francine ^{a,b,c,d,e,f,g,h,i}   Jacob, Marie Christine ^{a,b,c,d,e,f,g,h,i,j}  

^a EPS Rhône Alpes Grenoble   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Medicine Faculty   (France)

^d HÔPITAL MICHALLON   (France)

^e Department of Ophthalmology Dijon Hospital   (France)

^f DUPUYTREN UNIVERSITY HOSPITAL   (France)

^g Centre Hospitalier de Bourg en Bresse   (France)

^h Centre Hospitalier de la Region d'Annecy   (France)

ⁱ AVICENNE HOSPITAL   (France)

^j ETABLISSEMENT FRANÇAIS DU SANG   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; GLYCOPROTEIN P 15095; GRANZYME B; HLA DR ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; MICROSOMAL AMINOPEPTIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL TRANSFORMATION; CHILD; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; INFLUENZA VIRUS; LEUKEMIA; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; TH2 CELL;

EID: 0035874538     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3210     Document Type: Article

References (40)

1. Kameoka J, Ichinohasama R, Tanaka M, et al. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature. Am J Clin Pathol. 1998;110:478-488.
2. Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol. 1994;47:278-282.
3. Brody JP, Allen S, Schulman P, et al. Acute agranular CD4-positive natural killer cell leukemia: comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer. 1995;75:2474-2483.
4. DiGiuseppe JA, Louie DC, Williams JE, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol. 1997;21:1223-1230.
5. Bagot M, Bouloc A, Charue D, Wechsler J, Bensussan A, Boumsell L. Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage? J Invest Dermatol. 1998;111:1242-1244.
6. Uchiyama N, Ito K, Kawai K, Sakamoto F, Takaki M, Ito M. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin. Am J Dermatopathol. 1998;20:513-517.
7. Petrella T, Dalac S, Maynadie M, et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol. 1999;23:137-146.
8. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytold T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997;185:1101-1111.
9. Galy A, Christopherson I, Feriazzo G, Liu G, Spits H, Georgopoulos K. Distinct signals control the hematopoiesis of lymphoid-related dendritic cells. Blood. 2000;95:128-137.
10. Res P, Martinez Caceres E, Cristina Jaleco A, et al. CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood. 1996;87:5196-5206.
11. Marquez C, Trigueros C, Fernandez E, Toribio ML. The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44. J Exp Med. 1995;181:475-483.
12. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 1994;82:487-493.
13. Kohrgruber N, Halanek N, Groger M, et al. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol. 1999;163:3250-3259.
14. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CD. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol. 1999;29:2769-2778.
15. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.
16. Res PC, Couwenberg F, Vyth Dreese FA, Spits H. Expression of pTalpha mRNA in a committed dendritic cell precursor in the human thymus. Blood. 1999;94:2647-2657.
17. Nathalie Bendriss-Vermare, Clarisse Barthélémy, Isabelle Durand, et al. Human thymus contains IFNα-producing CD11c- and myeloid CD11c+ dendritic cells as well as mature interdigitating dendritic cells. J Clin Invest. In press.
18. Sorg RV, Kögler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c-population. Blood. 1999;93:2302-2307.
19. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186.
20. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835-1837.
21. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:305-310.
22. Kadowaki N, Antonenko S, Lau JY, Liu YJ. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med. 2000;192:219-226.
23. Steinman R, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med. 2000;191:411-416.
24. Liu YJ, Blom B. Introduction: TH2-Inclucing DC2 for immunotherapy. Blood. 2000;95:2482-2483.
25. Plumas J, Chaperot L, Jacob MC, et al. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells. Eur J Immunol. 1995;25:3332-3341.
26. Plumas J, Jacob MC, Chaperot L, Molens JP, Sotto JJ, Bensa JC. Tumor B cells from nonHodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-medlated apoptosis. Blood. 1998;91:2875-2885.
27. Chaperot L, Chokri M, Jacob MC, et al. Differentiation of antigen presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma. Leukemia. 2000;14:1667-1677.
28. Jacob MC, Favre M, Bensa JC. Membrane cell permeabilization with saponin and multiparametric analysis by flow cytometry. Cytometry. 1991;12:550-558.
29. Strobl H, Scheinecker C, Riedl E, et al. Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. J Immunol. 1998;161:740-748.
30. Palucka K, Banchereau J. Linking innate and adaptive immunity. Nat Med. 1999;5:868-870.
31. Hagmann M. Elusive interferon alpha producers nailed down. Science. 1999;284:1746.
32. Bottomly K. T cells and dendritic cells get intimate. Science. 1999;283:1124-1125.
33. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 1995;3:459-473.
34. Plum J, De Smedt M, Verhasselt B, et al. In vitro Intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split. J Immunol. 1999;162:60-68.
35. Olweus J, BitMansour A, Warnke R, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A. 1997;94:12551-12556.
36. Drach J, Gattringer C, Huber H. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol. 1991;83:418-422.
37. Scott A, Head D, Kopecky K, et al. HLA-DR, CD33+, CD56+, CD16-myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.
38. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia. 1994;8:823-826.
39. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000;95:3489-3497.
40. Lacombe F, Durrieu F, Briais A, et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 1997;11:1878-1886.